Optimal Timing, Cutoff, and Method of Calculation of Preoperative Prostate-Specific Antigen Velocity to Predict Relapse After Prostatectomy: A Report from SEARCH

Urology

Volumn 69, Issue 4, 2007, Pages 732-737

  King, Christopher R ^a   Freedland, Stephen J ^b,c   Terris, Martha K ^d,e   Aronson, William J ^f,g   Kane, Christopher J ^h,i   Amling, Christopher L ^j,k   Presti Jr , Joseph C ^a,l  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j Alabama   (United States)

^k NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^l VA PALO ALTO HEALTH CARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HISTORY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RELAPSE; SEARCH ENGINE; TIME; UNIVARIATE ANALYSIS; VELOCITY;

AGED; HUMANS; MALE; MATHEMATICS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 34147137270     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.019     Document Type: Article

References (12)

1. D'Amico A.V., Chen M.-H., Roehl K.A., et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 121-135
2. Patel D.A., Presti J.C., McNeal J.E., et al. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol 23 (2005) 6157-6162
3. Sengupta S., Myers R.P., Slezak J.M., et al. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. J Urol 174 (2005) 2191-2196
4. D'Amico A.V., Renshaw A.A., Sussman B., et al. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294 (2005) 440-447
5. Freedland S.J., Aronson W.J., Kane C.J., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital study group. J Clin Oncol 22 (2004) 446-453
6. th ed. (2002), Springer Verlag, New York 309-313
7. Gleason D.F., and Veterans Administration Cooperative Urological Research Group. Histological grading and staging of prostatic carcinoma. In: Tannenbaum M. (Ed). Urologic Pathology: The Prostate (1977), Lea & Febiger, Philadelphia 171-187
8. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Yu X., Han M., Gashti S.N., et al. Comparison of different methods for calculating PSA velocity: importance of time interval prior to diagnosis of prostate cancer (abstract). J Urol 173 (2005) 128
10. Carter H.B., Peasron J.D., Waclawiw Z., et al. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology 45 (1995) 591-596
11. Carter H.B., and Pearson J.D. Prostate-specific antigen velocity and repeated measures of prostate-specific antigen. Urol Clin North Am 24 (1997) 333-338
12. Freedland S.J., Dorey F., and Aaronson W.J. Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy. Urology 57 (2001) 476-480